 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 2000, 20(24):9111-9118
Dominant Role of the Cytosolic C-Terminal Domain of the Rat
5-HT1B Receptor in Axonal-Apical Targeting
Nicolas
Jolimay,
Louis
Franck,
Xavier
Langlois,
Michel
Hamon, and
Michèle
Darmon
Institut National de la Santé et de la Recherche
Médicale U288, Faculté de Médecine
Pitié-Salpêtrière, 75013 Paris, France
 |
ABSTRACT |
The 5-HT1A and 5-HT1B receptors for
serotonin exhibit a different membrane localization to either soma and
dendrites (5-HT1AR) or axons and terminals
(5-HT1BR) of neurons in the CNS. The mechanisms responsible for their differential targeting were investigated previously by transfecting various
5-HT1AR/5-HT1BR chimeras in the epithelial
Lilly pork kidney (LLC-PK1) cell line. This first study
suggested that a specific targeting signal is located in the C-terminal
portion (comprising the last two transmembrane and the cytoplasmic
C-terminal domains) of the 5-HT1Aand/or 5-HT1B receptors. In the present study, the role of the cytosolic C-terminal tail of the receptors was further investigated by transfecting truncated receptors and 5-HT1AR/5-HT1BR
chimeras in both the epithelial LLC-PK1 cells and rat hippocampal
neurons in primary culture. Confocal microscopic analysis of
immunofluorescence with specific anti-5-HTR antibodies and
anti-microtubule-associated protein 2 or anti-neurofilament 200k
antibodies showed that substitution of the cytosolic C-terminal tail of
the 5-HT1BR in the 5-HT1AR addressed the
resulting chimera to the axon of neurons and to the apical domain of
LLC-PK1 cells. Therefore, the short tail of the 5-HT1BR
presents an apical targeting signal that can also act as an axonal
targeting signal. In addition, a domain within the third
intracytoplasmic loop of the 5-HT1BR, responsible for its
Golgi sequestration in LLC-PK1 cells, appeared to act as another axonal
targeting signal in hippocampal neurons.
Key words:
cell polarity; addressing mechanisms; axons; dendrites; serotonin receptors; 5-HT1AR; 5-HT1BR
 |
INTRODUCTION |
The serotonin-1A
(5-HT1AR) and serotonin-1B
(5-HT1BR) receptors are two G-protein-coupled
receptors. These serotonin (5-hydroxytryptamine, 5-HT) receptors belong
to the 5-HT1 family showing a high affinity for
serotonin, are negatively coupled with adenylyl cyclase, and share 43%
identity in their amino acid sequences, mainly within the transmembrane
domains (Barnes and Sharp, 1999 ). Neuronal functions of these receptors
depend on their localization. Whereas the 5-HT1AR modulates the firing of serotonergic neurons in the raphe nuclei (Haj-Dahmane et al., 1991 ), the 5-HT1BR
participates in a local control of serotonin release from axon
terminals in their projection areas (Engel et al., 1986 ). Their
distribution, investigated by specific radioligand binding, in
situ hybridization, and immunohistochemistry, showed a good
colocalization of the mRNA and the protein for the 5-HT1AR (Miquel et al., 1991 ; Pompeiano et al.,
1992 ), whereas in contrast, the 5-HT1BR appeared
to be localized in different areas compared with its mRNA (Boschert et
al., 1994 ; Doucet et al., 1995 ). Immunocytochemistry at the electron
microscope level confirmed that the 5-HT1AR is
localized on the soma and dendrites of neurons (Kia et al., 1996 ; Riad
et al., 2000 ), whereas the 5-HT1BR is in
preterminal unmyelinated axons (Sari et al., 1999 ; Riad et al., 2000 )
throughout the rat CNS.
We first investigated the origin of the differential targeting of the
5-HT1A and 5-HT1B receptors
by expressing them in polarized epithelial Lilly Pork Kidney (LLC-PK1)
cells. Indeed, Dotti and Simons (1990) made the hypothesis that
epithelial cells and neurons share common mechanisms of protein
targeting, with the apical domain being the equivalent of axons and the
basolateral domain corresponding to the soma and dendrites,
respectively. Previous studies showed that the
5-HT1BR stayed in a Golgi-like intracellular compartment in both LLC-PK1 cells (Langlois et al., 1996 ) and Madin-Darby canine kidney II (MDCKII) cells (Ghavami et al., 1999 ). In
contrast, the 5-HT1AR was targeted mainly to the
basolateral domain of the plasma membrane in LLC-PK1 cells and to both
its apical and basolateral domains in MDCKII cells. Subsequent analysis of the targeting of chimeras of 5-HT1AR and
5-HT1BR in LLC-PK1 cells revealed that the
5-HT1BR and all the chimeras containing its third
intracellular domain (I3) were localized in the Golgi apparatus (Darmon
et al., 1998 ), suggesting that this domain was responsible for
intra-Golgi sequestration. In addition, the different localization of
two chimeras that differ in their C-terminal portion suggested that a
specific targeting signal was located in the C-terminal portion of the
5-HT1AR and/or 5-HT1BR.
In the present study, we have constructed new chimeras and
truncated receptors to identify the targeting signals of the
5-HT1AR and/or 5-HT1BR.
Chimeras were expressed by stable transfection in LLC-PK1 cells. We
have, in addition, compared their targeting with that observed in
another expression system: primary cultures of rat hippocampal neurons
cocultured with glial cells. These neurons were transfected with
plasmids containing the cDNAs of the 5-HT1AR,
5-HT1BR, or
5-HT1AR/5-HT1BR chimeras.
Their targeting in axons and/or dendrites was visualized by
immunofluorescence and analyzed by confocal microscopy.
 |
MATERIALS AND METHODS |
Materials. Antibodies used to detect rat
5-HT1AR (El Mestikawy et al., 1990 ) and
5-HT1BR (Langlois et al., 1995 ) have been described previously. Both are polyclonal rabbit antibodies directed against peptides located within the third intracellular domain of the
receptors. Mouse monoclonal microtubule-associated protein 2 (MAP2)
antibody is the AP20 clone (Roche, Meylan, France), and mouse
monoclonal neurofilament 200k (NF200k) antibody corresponds to the RT97
clone (Roche) that recognizes a phosphorylated form of NF200k.
LLC-PK1 cell culture and primary cultures of hippocampal
neurons. LLC-PK1 cells were grown essentially as described
previously (Darmon et al., 1998 ) in DMEM supplemented with 10%
fetal bovine serum. Stably transfected clones were selected in the
presence of 1.25 mg/ml G418 and maintained in 0.4 mg/ml G418 (Life
Technologies, Cergy Pontoise, France). Neuronal cultures were performed
essentially as described by Goslin et al. (1998) with some
modifications. Hippocampi of rat embryos were dissected at day 17-18.
Dissociation was achieved after trypsinization, with a Pasteur pipette.
Cells were counted and plated on
poly-L-lysine-coated 12-mm-diameter coverslips,
at a density of 60,000-75,000 cells per 16 mm dish (300-375 per
square millimeter), in complete Neurobasal medium supplemented with B27 (Life Technologies), containing 1 mM L-glutamine, 25 µM -mercaptoethanol, and penicillin G (10 U/ml)-streptomycin (10 mg/ml). Four hours after plating, the
coverslips were transferred to a confluent plate of glial cells and
maintained for 24 hr in complete Neurobasal medium. The medium was
partially changed every 3-4 d.
Construction of chimeric receptors. The chimeras A to
F are those described by Darmon et al. (1998) . Truncated receptors
deleted in the C-terminal tail were constructed by insertion of a stop codon, by PCR using two complementary oligonucleotides containing the
mutation. Only the sense oligonucleotides are listed below, with the
mutated nucleotides as bold letters and the stop codon underlined. The name of each oligonucleotide contains the
position of the stop codon in the nucleotide sequence of the rat
5-HT1AR (Albert et al., 1990 ) and
5-HT1BR (Hamblin et al., 1992 ). The chimera 1ActB
was constructed by PCR by using a hybrid oligonucleotide (Oligo 1ActB)
containing a 3' priming sequence corresponding to the
5-HT1BR (italics) and the 5' sequence
corresponding to the 5-HT1AR (bold),
and conversely for the other chimera 1BctA. The corresponding amino
acid sequences are indicated in parentheses: Oligo
1A 1320, CCGGTTATTTGAGCTTATTTCAAC
(PVIstop) for the truncated 1A 400; Oligo 1A 1345,
TTCAACAAAGACTAGCAAAACGC (FNKDstop) for the
truncated 1A 407; Oligo 1B 1580,
CCCCATCATCTGAACCATGTCCAATG (PIIstop) for
the truncated 1B 365; Oligo 1B 1605,
CAATGAGGACTAGAAACAAGCATT (NEDstop) for the
truncated 1B 372; Oligo 1ActB,
GCTTATTTCAACAAAGACTTTAAACAAGCAGCATTCCATAAAC (AYFNKDKQAFHKLI); and Oligo 1BctA,
ACCATGTCCAATGAGGACTTCCAAAACGCTTTTAAGAAG (TMSNEDFQNAFKK).
The mutations were confirmed by sequencing the whole coding sequence.
Insertion was made in the same pCB6 vector as that used for the former
chimeras (Darmon et al., 1998 ).
Transfection. Transfection was performed with the cationic
polymer polyethyleneimine (PEI) (25 kDa; Aldrich, Saint Quentin Fallavier, France), which complexes the anionic charges of the DNA
(Lambert et al., 1996 ). In the present case, 1 µl of 0.1 M PEI solution contained 100 nmol of amine
charges and complexed 33 µg of DNA. In our hands, neurons were not
transfectable until 3 d after plating. Neutralization of the
anionic charges of the different DNA preparations by the cationic
polymer PEI was tested by complexation with different amounts of PEI,
to determine the amount of PEI that completely complexed 1 µg of DNA
and prevented its migration in agarose gel (Martres et al., 1998 ). This
amount was named the PEI charge equivalent. An efficient transfection occurred only when a threefold to sixfold PEI charge equivalent was
used for complexation. For our DNA constructs, four different transfections were performed with a threefold, fourfold, fivefold, or
sixfold PEI charge equivalent, and the best conditions of transfection were analyzed by immunofluorescence and confocal microscopy. DNA (1 µg) and PEI were each diluted in 50 µl of Neurobasal medium without
B27 supplement. The PEI solution was added to the DNA dilution, mixed,
and left for 10 min at room temperature. The complex was then mixed
with 900 µl of complete Neurobasal medium, and 450 µl of the
resulting dilution was immediately added to the wells containing the
coverslip of neurons that had been removed from the glial plate.
Transfection lasted 4 hr at 37°C. The previous medium removed from
the glial plate was added back to the neurons and left for 2 d
until the immunofluorescence experiments.
Indirect immunofluorescence. For neurons, immunofluorescence
was performed from 8 to 15 d after plating and always 2 d
after transfection. For LLC-PK1 cells, stably transfected clones were grown on coverslips up to 7 d after confluency. Coverslips were washed twice with PBS+ (PBS containing 0.1 mM CaCl2 and 0.1 mM MgCl2) and fixed with
4% paraformaldehyde in PBS+, and, after three washes of 10 min in
PBS+, they were incubated for 1 hr in antibody buffer [3% bovine
serum albumin, 2% normal donkey serum, 2% normal goat serum
(Interchim, Montluçon, France), and 0.3% Triton X-100 in PBS+].
Incubation with the primary antibodies was performed in the antibody
buffer for 2 hr at room temperature. After three washes of 10 min with
PBS+, incubation with the secondary antibodies proceeded for 1 hr. The
secondary antibodies used were CY3-conjugated donkey anti-rabbit Ig
(1:1000 dilution; Interchim) and either CY2-conjugated (1:400;
Amersham, Les Ulis, France) or Alexa 488-conjugated (1:1000; Interchim)
goat anti-mouse Ig. The coverslips were finally mounted in
Fluoromount-G solution (Clinisciences, Montrouge, France).
Immunofluorescent images were generated using a Leica (Rueil-Malmaison,
France) TCS-400 laser scanning confocal microscope. Contrast and
brightness were chosen to ensure that all pixels were within linear
range. Images are the product of eightfold line average. The
x-z sections were produced using a 0.2 µm motor step. For
double-labeling experiments, pictures were generated using Adobe
Photoshop 5.0 (Adobe Systems, San Jose, CA). For each construct, the
transfection in neurons was performed at least three times, and at
least 10 neurons were analyzed with confocal microscopy each time. One
representative neuron was chosen for the figures.
Cell surface biotinylation experiments. Transfected cells
were grown for 7 d after confluency on 24-mm-diameter filter
inserts (Transwell; pore size, 0.45 µm; Costar, Cambridge, MA) and
biotinylated at either side as described previously (Darmon et al.,
1998 ). Proteins were separated by electrophoresis, transferred to
nitrocellulose, and probed with 5-HT1AR
antibodies at 1:1000. After incubation with anti-rabbit antibodies
coupled to horseradish peroxidase, revelation was performed with the
ECL+ kit (Amersham), and detection of the fluorescent product was
performed using a Fuji (Raytest, Courbevoie, France) FLA 2000 Phosphoimager, with excitation at 473 nm and emission at 520 nm.
Linearity of detection is within a range of 0-100 with this apparatus.
 |
RESULTS |
Truncated 5-HT1AR and 5-HT1BR are confined
intracellularly in LLC-PK1 cells
Previous studies on the mechanisms responsible for the
differential targeting of
5-HT1AR/5-HT1BR chimeras in
LLC-PK1 cells suggested that inclusion of the last two transmembrane
domains and the cytosolic tail of the 5-HT1AR
(chimera D) (Table 1) or of
the 5-HT1BR (chimera E) in their sequence led to
a basolateral or an apical targeting, respectively (Darmon et al.,
1998 ). First, we determined whether truncation of the cytosolic C-tail
after the seventh transmembrane domain of 5-HT1AR
or 5-HT1BR could redirect by default their apical
or basolateral localization because of the deletion of a targeting
signal. In contrast to the basolateral localization of the
5-HT1AR (Fig.
1A) or the Golgi-like
intracellular localization of the 5-HT1BR (Fig.
1B), large amounts of the truncated 5-HT1AR and 5-HT1BR (Table
1) were detected intracellularly in LLC-PK1 cells transfected with the
corresponding plasmids. Figure 1C shows that truncated
5-HT1AR (1A 400) is retained in the endoplasmic reticulum (ER) of transfected cells and proceeds no further. Similarly, the truncated 5-HT1BR, 1B 365, failed to reach
the cell surface and remained intracellularly in a compartment that
resembles the ER (Fig. 1D) but, in addition, seems to
be located in large vesicles. This truncated receptor could not yield
stable transfection, and the transient transfected cells might
synthesize excessive amounts of the protein that are stored in
lysosomes for degradation. Indeed, double labeling with a Golgi marker
did not show colocalization (data not shown), suggesting that these
vesicles did not belong to the Golgi apparatus. Previously, chimera B
was found to be localized in the endoplasmic reticulum and did not
exhibit any binding properties in experiments with selective
radioligands of each receptor. On Western blot, the corresponding
protein appeared to be nonglycosylated (Darmon et al., 1998 ).
Apparently, the truncated receptors had the same localization as
chimera B. The intracellular localization of truncated
5-HT1AR and 5-HT1BR may
reflect an unstable structure that does not exit from the ER. These
results suggest that 5-HT1AR and
5-HT1BR are excluded from the plasma membrane in
the absence of their cytosolic tail. Because truncation was made at the
very limit of the seventh transmembrane domain, some destabilization of
the latter domain might have occurred. Accordingly, new deletion
mutants of 5-HT1AR (1A 407) and
5-HT1BR (1B 372) were constructed (Table 1).
These mutants lacked the C-terminal domain but kept a few amino acids
beyond the seventh transmembrane domain. In that case too, the
resulting truncated receptors failed to reach the plasma membrane (Fig.
1E,F).

View larger version (80K):
[in this window]
[in a new window]
|
Figure 1.
Localization of 5-HT1AR,
5-HT1BR, and chimeras of receptors in transfected LLC-PK1
cells. Confocal immunofluorescence detection of labeling performed with
anti-5-HT1AR and anti-5-HT1BR antibodies and
revealed by CY3-conjugated anti-rabbit antibodies. 5-HT1AR
(A), 5-HT1BR
(B), 1A 400 (C), and
1A 407 (E) (truncated receptors) and 1ActB
(G, I) are stably transfected in
LLC-PK1 cells. The truncated 1B 365 (D),
1B 372 (F), and the chimera 1BctA
(H) are visualized in transiently
transfected LLC-PK1 cells. In contrast to the basolateral localization
of 5-HT1AR (A), the truncated
1A 400 (C) and 1A 407
(E) are localized in an intracellular compartment
that resembles the endoplasmic reticulum. The 5-HT1BR,
truncated 1B 365 (D) and 1B 372
(F), and 1BctA (H)
are also confined intracellularly. The chimera 1ActB exhibits a
punctate staining in a confocal analysis of an apical plane of 0.2 µm
(x-y; G), typical of an apical localization
visualized also in z-cut detection
(I). The horizontal dashed
line indicates the surface of the coverslip. Scale bar, 10 µm.
|
|
The cytosolic C-terminal domain of 5-HT1BR addresses
the 5-HT1AR/5-HT1BR chimeras to the apical
domain in LLC-PK1 cells
We substituted the cytosolic tail of 5-HT1BR
in the 5-HT1AR and vice versa. The first type of
5-HT1AR/5-HT1BR chimera was constructed in such a way that the 15 amino acids of the
5-HT1BR tail were joined just after the
5-HT1A seventh transmembrane domain. The
resulting chimeric receptor 1ActB was then stably transfected in
LLC-PK1 cells. Immunofluorescence of 1ActB-expressing cells visualized
in the x-y plane revealed a punctate immunostaining (Fig.
1G). This typical staining characterizes epithelial
microvilli and indicates that 1ActB chimera was localized at the apical
domain. Confocal z-cut analysis confirmed a
predominant apical localization of chimeric 1ActB receptor (Fig.
1I). This result showed that substitution of the
5-HT1AR tail for that of
5-HT1BR redirected the basolateral
5-HT1AR to the apical pole. Binding experiments with [3H]alnespirone (Fabre et al.,
1997 ) showed that this chimera could bind the specific agonist of
5-HT1AR (data not shown).
In the same way, we explored the existence of a putative sorting signal
in the cytosolic tail of 5-HT1AR by creating the
reverse mutant 1BctA consisting of the native
5-HT1BR fused to the
5-HT1AR cytosolic tail (Table 1). However, 1BctA
chimera gave no stable transfected clone, despite several transfection
experiments. This chimera presented a clearly intracellular retention
in LLC-PK1 cells transiently transfected with the 1BctA encoding
sequence (Fig. 1H). Probably, synthesis of 1BctA is
immediately followed by removal and degradation before any plasma
membrane insertion.
To quantify the targeting of 1ActB chimera, the same clonal cell line
as that used in immunofluorescence experiments was grown on Transwell
filters and biotinylated at either apical or basolateral surface.
Biotinylated proteins were precipitated by streptavidin agarose,
separated by PAGE, and detected on a nitrocellulose membrane with 5-HT1AR-specific antibodies. As expected,
1ActB appeared to be targeted predominantly to the apical surface of
LLC-PK1 cells (Fig.
2A). Quantification
yielded values three times higher for apical than basolateral
biotinylation (Fig. 2B). In contrast, biotinylation
of the 5-HT1AR was larger at the basolateral
surface (Fig. 2A,B), whereas
tail-out (1A 400, 1A 407, 1B 365, and 1B 372) and 1BctA
tail-swapped mutants having no plasma membrane localization could not
be labeled by the biotinylation procedure (data not shown).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 2.
Apical predominance of 1ActB chimera in stably
transfected LLC-PK1 cells. A, After apical
(Ap) and basolateral (Bl)
biotinylation of membrane proteins of stably transfected cells cultured
on Transwell filters, extracts were separated by PAGE. Detection was
performed on nitrocellulose membrane with 5-HT1AR
antibodies and ECL+ Western blotting detection system (Amersham).
Molecular weights of markers are indicated in kilodaltons.
B, Bars represent the apical or basolateral
labeling compared with the total receptor content on the cell surface
(in percent, mean ± SD). Three quantifications were performed on
one or two different immunoblots from three independent biotinylation
experiments. The ECL+ fluorescence was quantified using a Fuji FLA-2000
Phosphoimager apparatus.
|
|
Polarized targeting of 5-HT1AR and 5-HT1BR
in hippocampal neurons
Hippocampal neurons were transfected with the same plasmids as
those used in LLC-PK1 cells. In this cell culture derived from immature
pyramidal cells of embryos at embryonic day 18 (E18), our
5-HT1BR antibodies did not detect any labeling in
nontransfected neurons, suggesting that, at this stage, pyramidal
neurons do not yet express the 5-HT1BR. A weak
signal in the soma of few neurons was detected with our
5-HT1AR antibodies, suggesting that the
expression of 5-HT1AR may begin earlier than that
of 5-HT1BR when pyramidal neurons are not yet
differentiated into CA1, CA2, and CA3 cell types. Figure
3 shows the detection of
5-HT1AR and 5-HT1BR 2 d after transfection (i.e., 15 d after plating), using a
double-labeling procedure. The labeling of
5-HT1AR (Fig. 3A, red)
showed a good colocalization with MAP2 labeling
(green), in accordance with its predominant
localization in dendrites. Accordingly, this expression system enabled
us to visualize an appropriate targeting of the
5-HT1AR with respect to its localization in the
CNS, i.e., a dendritic targeting and an axonal exclusion. Neurons
transfected with the 5-HT1BR showed a labeling of
the axon, as revealed by the double labeling with NF200k antibody (Fig.
3D). The double labeling with MAP2 antibody (Fig.
3C) confirmed that, in addition to the axon, dendrites were
labeled with 5-HT1BR antibodies. These
observations indicate that the 5-HT1BR followed an axonal targeting, without dendritic exclusion. These results are in
accordance with those obtained for metabotropic glutamate receptors
expressed from recombinant viral vector in primary cultures of
hippocampal neurons (Stowell and Craig, 1999 ). Indeed, metabotropic glutamate receptor 1 (mGluR1) and mGluR2 (like the
5-HT1AR) were found to exhibit a dendritic
targeting with an axonal exclusion, whereas mGluR7 (like the
5-HT1BR) was characterized by a dominant axonal
targeting in addition to a dendritic localization. Accordingly, this
culture system reproduces the differential targeting of receptors in
axons but not in dendrites and can be used to identify axonal but not
somatodendritic targeting signals. Dendritic localization of the
5-HT1BR could be attributable to
overexpression resulting from the strong promoter present in the
plasmid used for transfection. However, Jareb and Banker (1998)
addressed this question about neurons infected by recombinant viruses
and showed that there was no significant correlation between the level
of expression and the degree of polarization for any of the apical
proteins that they studied.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 3.
Somatodendritictargetingof
5-HT1AR and chimera D and axonal targeting of
5-HT1BR in cultured hippocampal neurons. Confocal
immunofluorescence detection of 5-HT1AR
(A), chimera D (B), and
5-HT1BR (C, D) appearing in
red with CY3-conjugated anti-rabbit antibodies and
either MAP2 (A-C) or NF200k
(D), detected in green with Alexa
488-conjugated anti-mouse antibodies, in transfected hippocampal
neurons. Colocalization of 5-HT1AR and chimera D with the
dendritic marker MAP2 is shown on the right with a
superposition of the two labels (red and
green) in a yellow/orange
color. The 5-HT1BR exhibits an axonal location that is
visualized as a thin red labeling around the cell body
and a distal labeling of the axon (C), in
addition to a dendritic location detected by a yellow
colocalization with MAP2. The double labeling of the
5-HT1BR and NF200k in the axon is shown in
D. Scale bars, 10 µm.
|
|
The third intracellular domain of the 5-HT1BR plays
different roles in receptor targeting in epithelial cells and
neurons
To better characterize the targeting signals of
5-HT1AR and 5-HT1BR in
hippocampal neurons, we tested the targeting of some chimeras of these
receptors that were already used in our study using LLC-PK1 cells
(Darmon et al., 1998 ). Table 1 shows a summary of the chimeras and
their previous localization in LLC-PK1 cells, as well as some new
chimeras, which we have constructed to delineate some potential
targeting signals. Our previous study had shown that the third
intracellular domain was responsible for the
5-HT1BR localization in the Golgi apparatus
(chimeras A and F) of LLC-PK1 cells. In addition, a chimera containing
the C-terminal domain of the 5-HT1BR (chimera E)
was targeted to the apical domain of these cells, suggesting the
existence of an apical targeting signal in the
5-HT1BR. On the other hand, the chimera D that
contains the C-terminal of the 5-HT1AR was
targeted to the basolateral domain of LLC-PK1 cells.
The targeting of chimeras A, E, and F in neurons is illustrated in
Figure 4. In contrast to what was
observed in LLC-PK1 cells, the three chimeras A, E, and F exhibited the
same targeting in neurons. For the three chimeras, the dendrites were
labeled (illustrated here only for the chimera E), as revealed by the
double labeling with MAP2 antibody (Fig. 4C). In addition, a
long axon labeled with the 5-HT1BR and NF200k
antibodies, but not with MAP2 antibody, confirmed the targeting
of these chimeras to the axon (Fig.
4A,B,D). These
observations showed that these three chimeras presented an axonal
targeting in addition to a dendritic localization.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 4.
Axonal targeting of chimera A, chimera F, and
chimera E in cultured hippocampal neurons. Confocal immunofluorescence
detection of chimera A (A), chimera F
(B), and chimera E (C,
D) in transfected hippocampal neurons. These three
chimeras exhibit an axonal targeting visualized by a long and thin
neurite in red (CY3-conjugated anti-rabbit antibodies)
and labeled by NF200k antibody in green
(arrow) (A, B,
D, Alexa 488-conjugated anti-mouse antibodies). This
axonal targeting is confirmed in a double-labeling experiment with the
MAP2 dendritic marker, which shows in addition to a double labeling of
dendrites, a long and thin neurite labeled only with the antibodies
directed against the 5-HT1BR for the chimeras A and F and
against the 5-HT1AR for the chimera E
(C). An arrowhead shows a labeled
terminal or a growth cone that is frequently detected with the chimera
E (D). Scale bars, 10 µm.
|
|
For the chimera D (Fig. 3B), we observed the same type of
labeling as for the 5-HT1AR: a dendritic
targeting with an axonal exclusion. The labeling of the dendrites
matched perfectly the labeling by MAP2 antibody. The two constructs
that were either nonfunctional in LLC-PK1 cells, chimera C, or
restricted to the ER, chimera B, were also nonfunctional in neurons or
were restricted to an inner compartment within the cell body (Fig.
5A), respectively.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 5.
Intracellular retention of chimeras B and 1BctA
and truncated receptors in hippocampal neurons. The chimeric and
truncated receptors B and 1A 400 are labeled with 5-HT1AR
antibodies (A, B) and 1B 365 and 1BctA
with 5-HT1BR antibodies (C,
D) and detected in red with
CY3-conjugated anti-rabbit antibodies. Each chimera (illustrated on the
right) exhibits an intracellular localization in the
soma of neurons with no labeling of neurites characterized by the
dendritic marker MAP2 (detected in green with Alexa
488-conjugated anti-mouse antibodies). Scale bars, 10 µm.
|
|
The cytoplasmic C-terminal domain of the 5-HT1BR
addresses the 5-HT1AR/5-HT1BR chimeras to the
axon of hippocampal neurons
To investigate the respective roles of the last two transmembrane
segments and the intracellular C-terminal domain, we first studied the
targeting of the different constructs of 5-HT1AR
and 5-HT1BR deleted in their C-terminal moiety.
In Figure 5 are shown the chimeras B and 1BctA, as well as the
truncated receptors 1A 400 and 1B 365. All these constructs, like
the 1BctA chimera, were restricted to an intracellular compartment
within the cell body of neurons similar to what was observed in LLC-PK1
cells. The truncated 1B 365 showed a weak signal in the proximal
dendrites (Fig. 5C), which can correspond to its
localization in the endoplasmic reticulum in dendrites. This result
strengthens the hypothesis of a misfolding of the protein when the
truncation in the cytosolic C-terminal domain is too close to the exit
of the seventh transmembrane domain from the plasma membrane. In
contrast, the chimera 1ActB exhibited an axonal localization as shown
in Figure 6. Indeed, the axon, clearly
identified as a thin and long neurite labeled by
5-HT1AR antibodies, was not labeled by MAP2
antibodies (Fig. 6A) but was labeled by NF200k
antibodies (Fig. 6B), therefore suggesting that an
axonal targeting signal was located in the small cytoplasmic C-terminal
domain of the 5-HT1BR. Interestingly, this same
sequence allowed an apical targeting in LLC-PK1 cells (Fig.
1G,I). Together, these results suggest the
existence of two axonal targeting signals in the
5-HT1BR, one in the C-terminal domain and the
other one in the third intracellular domain. The comparison of the
results obtained in LLC-PK1 cells suggests that these signals do not
function in the same way in epithelial and neuronal cells.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 6.
Axonal localization of the chimera 1ActB in
neuronal cultures. Confocal immunofluorescence detection of 1ActB
chimera detected in red with 5-HT1AR
antibodies and CY3-conjugated anti-rabbit antibodies in transfected
cultured hippocampal cells (middle panels). MAP2
(A) and NF200k (B)
antibodies are detected in green with Alexa
488-conjugated anti-mouse secondary antibodies. In the right
panels of A and B, the
superimposition of the two labelings is shown. Arrows
point at 5-HT1AR-immunoreactive axons devoid of MAP2
labeling (A) but labeled by NF200k antibody
(B). C, Schematic description of
the chimera 1ActB; sequence originating from the 5-HT1AR is
in black and from the 5-HT1BR in
gray. Scale bars, 10 µm.
|
|
 |
DISCUSSION |
All of these experiments showed that the cytosolic C-terminal
domain of the 5-HT1BR, when substituted for that
of the 5-HT1AR, can address the
5-HT1AR to the apical domain of LLC-PK1 cells and
to the axon of hippocampal neurons, suggesting that the
5-HT1BR exhibits an apical-axonal targeting
signal. In addition, comparison of the targeting of various chimeras in
LLC-PK1 cells and neurons suggests that the second axonal targeting
signal located in the third intracellular domain of the
5-HT1BR is not recognized as an apical targeting
signal in LLC-PK1 cells.
In the present study, the 5-HT1AR and
5-HT1BR without their C-terminal domains were
confined intracellularly in both epithelial cells and neurons. These
observations suggest that recombinant receptors require their short
C-terminal tail for the preservation of their three-dimensional
structure and correct folding. Many natural and artificial
mutations have already been observed to result in ER retention because
they affect protein folding or oligomerization (Klausner and Sitia,
1990 ). For example, the betaine transporter with a short deletion in
C-terminal fails to reach the cell surface (Perego et al., 1997 ). The
E-cadherin protein when truncated in its C-terminal domain also
exhibits an ER localization (Chen et al., 1999 ).
Previous studies on
5-HT1AR/5-HT1BR chimeras
(Darmon et al., 1998 ) showed that the last two transmembrane domains
and the cytosolic C-terminal tail of either
5-HT1AR or 5-HT1BR include a targeting signal. The apical localization of the chimera 1ActB in
LLC-PK1 cells suggests that this signal is restricted to the cytosolic
C-terminal tail of one or the other receptor. Unfortunately, the
intracellular localization of truncated receptors does not help to
understand the apical localization of the chimera 1ActB. Is it
attributable to a dominant apical targeting signal in
5-HT1BR or to a dominant basolateral targeting
signal in 5-HT1AR, disrupted by the substitution
and leading to the use of an apical default pathway? Limitations of
this epithelial model prompted us to study the targeting of these
polytopic neuronal proteins in cultured neurons.
Transfections of the 5-HT1AR and
5-HT1BR in primary cultures of hippocampal
neurons showed that the 5-HT1AR was targeted to the dendrites with an axonal exclusion, whereas the
5-HT1BR showed an axonal targeting in addition to
a dendritic localization. The fact that a membrane-bound protein such
as the 5-HT1BR was present in dendrites in
addition to its axonal targeting has also been shown in the same
culture system for the mGluR7 receptor (Stowell and Craig, 1999 ) and
for the GABA transporter GAT-3 (Ahn et al., 1996 ), which are both
localized in axons in the CNS. For the targeting of the
5-HT1BR, this culture system is more appropriate
than the LLC-PK1 cell line because the receptor is actually inserted
within the plasma membrane of cultured neurons, whereas it is confined to intracellular compartments in the latter cells. However, in contrast
to that expected from the subcellular localization of 5-HT1BR in the CNS, its axonal localization is
not accompanied by a dendritic exclusion in transfected neurons. At the
adult stage, pyramidal neurons from CA1, CA2, and CA3 areas express naturally the 5-HT1AR mRNA (Miquel et al., 1991 ),
but only CA1 pyramidal neurons express the
5-HT1BR mRNA (Neumaier et al., 1996 ). However, at
E18, when fetal tissues are taken for setting up the primary cultures,
the CA1 and CA3 neurons are not yet differentiated and may not possess
the machinery for a dendritic exclusion of the
5-HT1BR. This would explain why
5-HT1BR in transfected hippocampal neurons was
addressed in both the axon and the somatodendritic compartment under
our experimental conditions. Furthermore, because all types of neurons
expressing 5-HT1AR and/or
5-HT1BR throughout the CNS have obviously not yet
been examined at a subcellular level, it cannot be excluded that the
sorting of these receptors might be different in different types of
neurons and at different stages of differentiation.
Interestingly, the chimera D, which exhibited a basolateral
localization in the LLC-PK1 cells, shows a dendritic localization like
that observed for the 5-HT1AR. This chimera,
which contains the third intracellular and C-terminal domains of the
5-HT1AR, could exhibit a targeting signal in one
or the other domain that restricts the localization to the
somatodendritic compartment. However, the chimeras A and F that have
the C-terminal domain of 5-HT1AR or the chimera E
that has the I3 domain of the 5-HT1AR are
targeted to the axon, thus ruling out the hypothesis of a dominant
somatodendritic targeting restriction signal in either domain. Data
concerning the chimeras E and 1ActB show that they are both targeted to
the axon of hippocampal neurons. These results support the idea that
the localization of the 5-HT1BR in the axon is
probably attributable to a dominant targeting signal located in the
C-terminal tail of the 5-HT1BR. Both chimeras are
also apical in LLC-PK1 cells, thus strengthening the hypothesis that the apical targeting signal can also be implicated in axonal targeting. In addition, the two constructs that were restricted to the Golgi apparatus in LLC-PK1 cells, i.e., chimeras A and F, are now targeted to
the axon. These two chimeras have in common the third intracellular loop of the 5-HT1BR, thereby suggesting the
existence of another axonal targeting signal in this portion of the
sequence. Interestingly, this second axonal targeting signal is
revealed when the C-terminal one is absent. In LLC-PK1 cells, this
signal was not recognized as an apical one and led to an intracellular
localization, probably because of the lack of a specific targeting
protein present in neurons and absent in LLC-PK1 cells.
The existence of two targeting signals in the same protein has already
been reported for the low-density lipoprotein receptor (Matter et al.,
1992 ), suggesting that proteins can have redundant signals. Here the
difference of targeting between epithelial cells and neurons concerning
the third intracellular domain further emphasizes the limits of the use
of epithelial cells as a model for studying the targeting of polytopic
neuronal proteins. The previous hypothesis that LLC-PK1 cells lack
addressing proteins that interact with the targeting signal located in
the third intracellular domain is therefore strengthened by these novel
data. All of these results together suggest that the machinery
responsible for the apical targeting may be different from that
responsible for the axonal targeting. This hypothesis has already been
suggested by Jareb and Banker (1998) , who concluded from the targeting
of various monotopic epithelial proteins expressed in neurons that the
targeting of basolateral and dendritic proteins depends on common
mechanisms, whereas the sorting of proteins to the axon requires
signals that are not present in apical proteins. Indeed, the epithelial
system appears to be useful to underline some important features in a given sequence (for example, the cytosolic tail of
5-HT1BR). However, the Golgi sequestration of the
5-HT1BR would not have been emphasized without
the comparison with the axonal localization in neurons. In any case,
comparison of the targeting between neurons and epithelial cells (Dotti
and Simons, 1990 ) has some limits, and we could have to shift to
another model as suggested by Colman (1999) , who proposed that the
axons and dendrites correspond in fact to the same epithelial compartment, the basolateral one, and that the differential sorting between axons and dendrites relies on mechanisms different from those
used between the apical and the basolateral domain.
The role of the C-terminal sequence in the targeting of polytopic
proteins in neurons has already been suggested by other studies.
Indeed, Poyatos et al. (2000) have shown that two dileucine motifs in
the cytosolic C-terminal tail of the glycine transporter GLYT1 can play
a role in its basolateral-somatodendritic localization. An axonal
targeting signal has been described in the C-terminal sequence of
polytopic proteins such as the GABA transporter GAT-3 (Muth et al.,
1998 ) and the metabotropic glutamate receptor mGluR7 (Stowell and
Craig, 1999 ). The existence of an apical sorting signal in the
cytoplasmic tail of rhodopsin has also been shown (Chuang and Sung,
1998 ). However, our study is the first one to show that an apical
targeting signal can also be used as an axonal signal. No identity
could be detected between the peptidic sequence of the cytoplasmic tail
of the 5-HT1BR and those of mGluR7, GAT-3, or
rhodopsin. No target motif for a PDZ (postsynaptic density/Discs large/zona occludens-1) protein (Niethammer et al., 1996 ) could be
found either. Indeed, the 5-HT1BR is a
presynaptic receptor that modulates the release of neurotransmitters
(5-HT, ACh, and GABA ... ), and we can suggest that the mechanisms
of targeting differ for presynaptic versus postsynaptic
receptors or transporters. PDZ proteins play a role in the clustering
of postsynaptic proteins, and we can imagine that another family of
proteins is involved in the axonal and/or presynaptic targeting.
Cytoplasmic domains may play a major role in the targeting of polytopic
proteins expressed in neurons by interacting with some specific
targeting proteins specialized for the differential targeting in axons
and terminals, in opposition with dendrites and postsynaptic densities.
One important step in these studies will be to isolate specific sorting
proteins that interact with the C-terminal sequence of the rat
5-HT1BR.
 |
FOOTNOTES |
Received July 17, 2000; revised Sept. 22, 2000; accepted Sept. 27, 2000.
This work was supported by grants from the Institut National de la
Santé et de la Recherche Médicale, the European Community (Biotech Bio4 CT 960752), and Bristol-Myers Squibb Foundation (unrestricted biomedical research grant). N.J. was the recipient of a
fellowship from the Conseil Général de la Vendée
during the performance of this study. We thank Dr. G. Barbin for
assistance in initial experiments and Drs. M. B. Emerit and S. Vyas for judicious comments on this manuscript.
Correspondence should be addressed to Michèle Darmon,
Institut National de la Santé et de la Recherche Médicale
U288, Faculté de Médecine
Pitié-Salpêtrière, 91 Boulevard de l'Hôpital, 75634 Paris Cedex 13, France. E-mail: darmon{at}ext.jussieu.fr.
Dr. Langlois's present address: Department of Biochemical
Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium.
 |
REFERENCES |
-
Ahn J,
Mundig O,
Muth TR,
Rudnick G,
Caplan MJ
(1996)
Polarized expression of GABA transporter in Madin-Darby Canine Kidney cells and cultured hippocampal neurons.
J Biol Chem
271:6917-6924[Abstract/Free Full Text].
-
Albert PR,
Zhou QY,
Van Tol HH,
Bunzow JR,
Civelli O
(1990)
Cloning, functional expression and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene.
J Biol Chem
265:5825-5832[Abstract/Free Full Text].
-
Barnes NM,
Sharp T
(1999)
A review of central 5-HT receptors and their function.
Neuropharmacology
38:1083-1152[Web of Science][Medline].
-
Boschert U,
Amara DA,
Segu L,
Hen R
(1994)
The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals.
Neuroscience
58:167-182[Web of Science][Medline].
-
Chen YT,
Stewart DB,
Nelson WJ
(1999)
Coupling assembly of the E-cadherin/beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells.
J Cell Biol
144:687-699[Abstract/Free Full Text].
-
Chuang JZ,
Sung CH
(1998)
The cytoplasmic tail of rhodopsin acts as a novel apical sorting signal in polarized MDCK cells.
J Cell Biol
142:1245-1256[Abstract/Free Full Text].
-
Colman DR
(1999)
Neuronal polarity and the epithelial metaphor.
Neuron
23:649-651[Web of Science][Medline].
-
Darmon M,
Langlois X,
Suffisseau L,
Fattaccini CM,
Hamon M
(1998)
Differential membrane targeting and pharmacological characterization of chimeras of rat serotonin 5-HT1A and 5-HT1B receptors expressed in epithelial LLC-PK1 cells.
J Neurochem
71:2294-2303[Web of Science][Medline].
-
Dotti CG,
Simons K
(1990)
Polarized sorting of viral glycoproteins to the axon and dendrites of hippocampal neurons in culture.
Cell
62:63-72[Web of Science][Medline].
-
Doucet E,
Riad M,
Laporte AM,
Vergé D,
Daval G,
Gozlan H,
Hamon M
(1995)
In situ hybridization evidence for the synthesis of the 5-HT1B receptor in serotoninergic neurones of anterior raphe nuclei in the rat brain.
Synapse
19:18-28[Web of Science][Medline].
-
El Mestikawy S,
Riad M,
Laporte AM,
Vergé D,
Daval G,
Gozlan H,
Hamon M
(1990)
Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide.
Neurosci Lett
118:189-192[Web of Science][Medline].
-
Engel G,
Göthert M,
Hoyer D,
Schlicker E,
Hillenbrand K
(1986)
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
Naunyn Schmiedebergs Arch Pharmacol
332:1-7[Web of Science][Medline].
-
Fabre V,
Boni C,
Mocaër E,
Lesourd M,
Hamon M,
Laporte AM
(1997)
[3H]Alnespirone: a novel specific radioligand of serotonin 5-HT1A receptors in the rat brain.
Eur J Pharmacol
337:297-308[Web of Science][Medline].
-
Ghavami A,
Stark KL,
Jareb M,
Ramboz S,
Segu L,
Hen R
(1999)
Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons.
J Cell Sci
112:967-976[Abstract].
-
Goslin K,
Asmussen H,
Banker G
(1998)
Rat hippocampal neurons in low-density culture.
In: Culturing nerve cells (Banker G,
Goslin K,
eds), pp 339-370. Cambridge, MA: MIT.
-
Haj-Dahmane S,
Hamon M,
Lanfumey L
(1991)
K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study.
Neuroscience
41:495-505[Web of Science][Medline].
-
Hamblin MW,
McGuffin RW,
Metcalf MA,
Dorsa DM,
Merchant KM
(1992)
Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors.
Mol Cell Neurosci
3:578-587.
-
Jareb M,
Banker G
(1998)
The polarized sorting of membrane proteins expressed in cultured hippocampal neurons using viral vectors.
Neuron
20:855-867[Web of Science][Medline].
-
Kia HK,
Miquel MC,
Brisorgueil MJ,
Daval G,
Riad M,
El Mestikawy S,
Hamon M,
Vergé D
(1996)
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system.
J Comp Neurol
365:289-305[Web of Science][Medline].
-
Klausner RD,
Sitia R
(1990)
Protein degradation in the endoplasmic reticulum.
Cell
62:611-614[Web of Science][Medline].
-
Lambert RC,
Maulet Y,
Dupont JL,
Mykita S,
Craig P,
Volsen S,
Feltz A
(1996)
Polyethylenimine-mediated DNA transfection of peripheral and central neurons in primary culture: probing Ca2+ channel structure and function with antisense oligonucleotides.
Mol Cell Neurosci
7:239-246[Web of Science][Medline].
-
Langlois X,
Gérard C,
Darmon M,
Chauveau J,
Hamon M,
El Mestikawy S
(1995)
Immunolabelling of central 5-HT1D
receptors in the rat, mouse and guinea-pig with a specific anti-peptide antiserum.
J Neurochem
65:2671-2681[Web of Science][Medline]. -
Langlois X,
El Mestikawy S,
Arpin M,
Triller A,
Hamon M,
Darmon M
(1996)
Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons.
Neuroscience
74:297-302[Web of Science][Medline].
-
Martres MP,
Demeneix B,
Hanoun N,
Hamon M,
Giros B
(1998)
Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain.
Eur J Neurosci
10:3607-3616[Web of Science][Medline].
-
Matter K,
Hunziker W,
Mellman I
(1992)
Basolateral sorting of LDL receptor in MDCK cells: the cytoplasmic domain contains two tyrosine-dependent targeting determinants.
Cell
71:741-753[Web of Science][Medline].
-
Miquel MC,
Doucet E,
Boni C,
El Mestikawy S,
Matthiessen L,
Daval G,
Hamon M
(1991)
Central serotonin1A receptors: respective distribution of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain.
Neurochem Int
19:453-465.
-
Muth TR,
Ahn J,
Caplan M
(1998)
Identification of sorting determinants in the C-terminal cytoplasmic tails of the gamma-aminobutyric acid transporters GAT-2 and GAT-3.
J Biol Chem
273:25616-25627[Abstract/Free Full Text].
-
Neumaier JF,
Szot P,
Peskind ER,
Dorsa DM,
Hamblin MW
(1996)
Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain.
Brain Res
722:50-58[Web of Science][Medline].
-
Niethammer M,
Kim E,
Sheng M
(1996)
Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases.
J Neurosci
16:2157-2163[Abstract/Free Full Text].
-
Perego C,
Bulbarelli A,
Longhi R,
Caimi M,
Villa A,
Caplan MJ,
Pietrini G
(1997)
Sorting of two polytopic proteins, the
-aminobutyric acid and betaine transporters, in polarized epithelial cells.
J Biol Chem
272:6584-6592[Abstract/Free Full Text]. -
Pompeiano M,
Palacios JM,
Mengod G
(1992)
Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding.
J Neurosci
12:440-453[Abstract].
-
Poyatos I,
Ruberti F,
Martinez-Maza R,
Gimenez C,
Dotti CG,
Zafra F
(2000)
Polarized distribution of glycine transporter isoforms in epithelial and neuronal cells.
Mol Cell Neurosci
15:99-111[Web of Science][Medline].
-
Riad M,
Garcia S,
Watkins KC,
Jodoin N,
Doucet E,
Langlois X,
El Mestikawy S,
Hamon M,
Descarries L
(2000)
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain.
J Comp Neurol
417:181-194[Web of Science][Medline].
-
Sari Y,
Miquel MC,
Brisorgueil MJ,
Ruiz G,
Doucet E,
Hamon M,
Vergé D
(1999)
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies.
Neuroscience
88:899-915[Web of Science][Medline].
-
Stowell JN,
Craig AM
(1999)
Axon/dendrite targeting of metabotropic glutamate receptors by their cytoplasmic carboxy-terminal domains.
Neuron
22:525-536[Web of Science][Medline].
Copyright © 2000 Society for Neuroscience 0270-6474/00/20249111-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. Carrel, J. Masson, S. Al Awabdh, C. B. Capra, Z. Lenkei, M. Hamon, M. B. Emerit, and M. Darmon
Targeting of the 5-HT1A Serotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B
J. Neurosci.,
August 6, 2008;
28(32):
8063 - 8073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Chmelar and N. M. Nathanson
Identification of a Novel Apical Sorting Motif and Mechanism of Targeting of the M2 Muscarinic Acetylcholine Receptor
J. Biol. Chem.,
November 17, 2006;
281(46):
35381 - 35396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Carrel, M. Hamon, and M. Darmon
Role of the C-terminal di-leucine motif of 5-HT1A and 5-HT1B serotonin receptors in plasma membrane targeting
J. Cell Sci.,
October 15, 2006;
119(20):
4276 - 4284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Hill, D. E. Williams, M. LeMasurier, R. A. Dumont, E. E. Strehler, and P. G. Gillespie
Splice-site A choice targets plasma-membrane Ca2+-ATPase isoform 2 to hair bundles.
J. Neurosci.,
June 7, 2006;
26(23):
6172 - 6180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Masson, M. Darmon, A. Conjard, N. Chuhma, N. Ropert, M. Thoby-Brisson, A. S. Foutz, S. Parrot, G. M. Miller, R. Jorisch, et al.
Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth.
J. Neurosci.,
April 26, 2006;
26(17):
4660 - 4671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leterrier, J. Laine, M. Darmon, H. Boudin, J. Rossier, and Z. Lenkei
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
J. Neurosci.,
March 22, 2006;
26(12):
3141 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-D. Qi, S. C. Wolff, and R. A. Nicholas
The Apical Targeting Signal of the P2Y2 Receptor Is Located in Its First Extracellular Loop
J. Biol. Chem.,
August 12, 2005;
280(32):
29169 - 29175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Inukai, A. M. Shewan, W. S. Pascoe, S. Katayama, D. E. James, and Y. Oka
Carboxy Terminus of Glucose Transporter 3 Contains an Apical Membrane Targeting Domain
Mol. Endocrinol.,
February 1, 2004;
18(2):
339 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-Q. Sun, R. Salkar, Sachchidanand, S. Xu, L. Zeng, M.-M. Zhou, and F. J. Suchy
A 14-Amino Acid Sequence with a beta -Turn Structure Is Required for Apical Membrane Sorting of the Rat Ileal Bile Acid Transporter
J. Biol. Chem.,
January 31, 2003;
278(6):
4000 - 4009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Wetherington and N. A. Lambert
Differential Desensitization of Responses Mediated by Presynaptic and Postsynaptic A1 Adenosine Receptors
J. Neurosci.,
February 15, 2002;
22(4):
1248 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|